JDRF Blog

Latest in Artificial pancreas

  • FDA Approves an Artificial Pancreas System for Children Aged 2-6 Years

    September 2, 2020

    The Food and Drug Administration (FDA) approved the Medtronic MiniMed 770G artificial pancreas system for use by children aged 2 to 6 with type 1 diabetes (T1D). It is the first marketed device that can automatically adjust insulin delivery based on continuous glucose monitoring (CGM) values for children aged 2-6 years.

  • Tandem Control-IQ Controls T1D in Children Ages 6 and Up

    August 28, 2020

    A clinical trial at four pediatric diabetes centers in the United States has found that a new artificial pancreas system—which automatically monitors...

  • Tandem Control-IQ—Now Authorized For Children

    June 17, 2020

    Tandem Diabetes announced FDA clearance of an expanded pediatric indication for the Tandem t:slim X2™ insulin pump with Control-IQ™ technology in children ages six and older.

  • JDRF and Gore Invest in Development of Implantable Insulin Delivery System

    January 22, 2020

    PhysioLogic Devices, a JDRF-funded company that is dedicated to transforming the treatment of type 1 diabetes (T1D), wants to develop the ThinPump™—a...

  • FDA Grants Breakthrough Device Status: iLet Bionic Pancreas

    December 23, 2019

    Earlier this week, Beta Bionics announced that the Food and Drug Administration (FDA) has granted breakthrough device designation to the company’s iLet...

  • FDA Authorizes a Second Artificial Pancreas System

    December 13, 2019

    The Food and Drug Administration (FDA) today authorized an algorithm that enables the second artificial pancreas system: The Control-IQ™ advanced hybrid closed...

  • This Stent is a Champion for Type 1 Diabetes Clinical Trials

    November 7, 2019

    Stent—Maribeth Stent—was diagnosed with type 1 diabetes (T1D) in the fall of 1997. “It was right around my second birthday,” said Maribeth....

  • Two T1D Technology Leaders Partnering to Drive Innovation and Choice

    June 11, 2019

    Two leading innovators in the T1D space have announced a collaborative partnership aimed at enabling those with T1D to select favorite devices,...

  • A New AP System by Tandem Shows Key Time-in-Range Benefits

    June 10, 2019

    A new artificial pancreas system that both doses and takes away insulin is showing critical benefits in helping those with type 1...

  • A DIY Approach to Artificial Pancreas Technology

    May 2, 2019

    What do Aaron Kowalski, Ph.D., president and CEO of JDRF, and Jeremy Pettus, M.D., an endocrinologist at the University of California San...